Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.
It’s a good thing there’s a list to help narrow your decision by letting you see the most popular Netflix shows. That’s right, every week, Netflix releases its list of the 10 most-watched TV ...
JE: Human genetic studies provide strong target validation for the role of PCSK9 in modulating LDL cholesterol (LDL-C) levels and the risk of coronary heart disease (CHD).
These lipoproteins wrap themselves around cholesterol molecules -- and deliver them to where they're needed most. There are two main types: high-density lipoproteins, called HDL and low-density ...